If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for non-opioid pain treatments that could help quell the still raging opioid ...

The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.

Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

For those most impacted and waiting for justice, 2025 can be a year of accountability. Here are two databases to track the settlement money ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic.

FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options.